Live Feeds

Source map — FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
Fierce Pharma news 60%
Reuters news 60%
Yahoo Finance news 60%
Bloomberg.com news 60%
Endpoints News news 60%
STAT news 60%
Financial Times news 60%
The New York Times news 60%
finance.yahoo.com news 50%